A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

GSK plc agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and ...

For Tracy Owen, eczema was much more than dry skin. It came to dictate every aspect of her life, from ­relationships to how she dressed.

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...

GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...

Fifty-one medicines from Himachal Pradesh pharmaceutical industries failed quality tests conducted by CDSCO. These included ...

According to a detailed report by the BBC, growing scientific evidence suggests that hypnosis can deliver real clinical benefits, sometimes outperforming conventional treatments in effectiveness, cost ...

GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...